Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | WTX-124 |
Synonyms | |
Therapy Description |
WTX-124 is an IL-2 pro-drug, which potential increases anti-tumor immune response (Cancer Res 2021;81(13_Suppl):Abstract nr 1723). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
WTX-124 | WTX124|WTX 124 | WTX-124 is an IL-2 pro-drug, which potential increases anti-tumor immune response (Cancer Res 2021;81(13_Suppl):Abstract nr 1723). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05479812 | Phase I | WTX-124 Pembrolizumab + WTX-124 | Dose Escalation Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors | Recruiting | USA | 0 |